Clinical Trial

Innsbruck Health Promotion Program

Study acronym: INNHEALTH
Recruiting
View on ClinicalTrials.gov →
Summary
The primary goal of this single-centre. single-arm, unblinded, pre-post interventional study is to evaluate whether a one-time health assessment and intervention affects the overall vascular health evaluated through the Life's Essential 8 overall vascular health score. Secondary goals of this study are, among others: * to describe incidence and prevalence of vascular risk-factors and behaviours * to explore prevalence and associations of health and disease in the general population with special focus on cardiovascular risk, cardiovascular diseases, markers of vascular health, signs and (prodromal) symptoms of neurodegeneration as well as psychosocial factors * to explore the prevalence of hearing disorders in the general population * to collect voice and speech samples to identify novel biomarkers that correlate to vascular health and/or hearing status
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-02-03; most recent amendment 2025-11-18.
Status change: Not Yet Recruiting → Recruiting 2025-05-13
Trial Details
NCT Number NCT06813677
Lead Sponsor VASCage GmbH
Collaborators: Oroboros Instruments, Med-El Corporation, Tirol Kiniken GmbH, Österreichische Gesundheitskasse
Conditions Assessment of Vascular Health Risk Factors
Enrollment 1,000 participants
Start Date 2025-05-01
Primary Completion 2027-01-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-19